SIgN hosts a strong in-house cluster of cutting-edge technology platforms. In particular, our world class Clinical Immunomonitoring Platform offers a wide range of applications from multi- dimensional deep immune-phenotyping and immunogenomics, to single-cell-based technologies and functional immune- imaging. These capabilities are highly applicable to translational studies, such as for the discovery and identification of novel biomarkers and therapeutic targets or monitoring of clinical trials. Our platforms are open to the scientific community through targeted research collaborations and in some cases, via a fee- for-service.